(Q73509458)
Statements
Suppression of cyclophosphamide induced diabetes development and pancreatic Th1 reactivity in NOD mice treated with the interleukin (IL)-12 antagonist IL-12(p40)2 (English)
Rothe H
O'Hara RM Jr
Martin S
scientific article published on 01 June 1997